Diaceutics (GB:DXRX) has released an update.
Diaceutics PLC has announced board changes with the stepping down of Deborah Davis as Non-Executive Chair, effective from October 1, 2024, after over three years in the role. She will be succeeded by co-founder and current Executive Director, Peter Keeling, who will also join the Remuneration and Audit & Risk Committees. The leadership transition is expected to continue the company’s growth and success in providing commercialisation solutions to the pharma and biotech industries.
For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.
